Wierenga Wendall, a director at Cytokinetics Inc. ($CYTK), sold shares on the open market once in the last year, totaling $769 thousand, with the most recent sale on April 21, 2025. These sales rank 5,509th among 11,678 insiders in our database, where the average is 8.6 million per person across 6.4 transactions on average. Wierenga Wendall made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 15, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 164 | $38.01 | 32,345.0000 | 118,410,689 | 0.51% | 0.00% |
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Not found | A | Common Stock | 6900 | $0.00 | 116,146.0000 | 92,926,000 | 6.32% | 0.01% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 7333 | $0.00 | 32,181.0000 | 118,410,689 | 29.51% | 0.01% |
| May 14, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| April 21, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 20000 | $38.46 | 24,848.0000 | 118,410,689 | 44.60% | 0.02% |
| April 21, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 118,410,689 | 100.00% | 0.02% |
| April 21, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 20000 | $6.21 | 44,848.0000 | 118,410,689 | 80.49% | 0.02% |
| April 15, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 162 | $38.56 | 24,848.0000 | 118,410,689 | 0.66% | 0.00% |
| Jan. 2, 2025 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 127 | $48.93 | 24,686.0000 | 0 | 0.52% | 0.00% |
| Dec. 16, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 742 | $7.37 | 25,301.0000 | 0 | 3.02% | 0.00% |
| Dec. 16, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 742 | $48.61 | 24,559.0000 | 0 | 2.93% | 0.00% |
| Dec. 16, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 742 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 25, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 742 | $50.00 | 24,559.0000 | 0 | 2.93% | 0.00% |
| Nov. 25, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 742 | $0.00 | 742.0000 | 0 | 50.00% | 0.00% |
| Nov. 25, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 742 | $7.37 | 25,301.0000 | 0 | 3.02% | 0.00% |
| Oct. 28, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 4452 | $52.25 | 24,559.0000 | 0 | 15.35% | 0.00% |
| Oct. 28, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 4452 | $0.00 | 1,484.0000 | 0 | 75.00% | 0.00% |
| Oct. 28, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 4452 | $7.37 | 29,011.0000 | 0 | 18.13% | 0.00% |
| Oct. 1, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 118 | $52.60 | 24,559.0000 | 0 | 0.48% | 0.00% |
| July 1, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 114 | $0.00 | 24,441.0000 | 0 | 0.47% | 0.00% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Not found | A | Common Stock | 3400 | $0.00 | 109,246.0000 | 68,175,000 | 3.21% | 0.00% |
| June 7, 2024 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 5600 | $0.00 | 24,327.0000 | 0 | 29.90% | 0.00% |
| May 15, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 74 | $84.12 | 18,727.0000 | 0 | 0.40% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 5000 | $4.44 | 23,653.0000 | 0 | 26.81% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 5000 | $73.60 | 18,653.0000 | 0 | 21.14% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 5000 | $4.44 | 23,653.0000 | 0 | 26.81% | 0.00% |
| Dec. 27, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 5000 | $73.60 | 18,653.0000 | 0 | 21.14% | 0.00% |
| Oct. 2, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 448 | $27.88 | 18,653.0000 | 0 | 2.46% | 0.00% |
| Aug. 21, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 6020 | $6.72 | 24,225.0000 | 0 | 33.07% | 0.00% |
| Aug. 21, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 6020 | $32.02 | 18,205.0000 | 0 | 24.85% | 0.00% |
| Aug. 21, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 6020 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 3, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 374 | $33.36 | 18,205.0000 | 0 | 2.10% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Crinetics Pharmaceuticals, Inc. | $CRNX | WIERENGA WENDALL | Director | A | Common Stock | 6000 | $0.00 | 105,846.0000 | 0 | 6.01% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 5000 | $0.00 | 17,831.0000 | 0 | 38.97% | 0.00% |
| May 10, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 298 | $37.71 | 12,831.0000 | 0 | 2.38% | 0.00% |
| Feb. 6, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Common Stock | 7000 | $6.72 | 19,533.0000 | 0 | 55.85% | 0.00% |
| Feb. 6, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | S | Common Stock | 7000 | $45.00 | 12,533.0000 | 0 | 35.84% | 0.00% |
| Feb. 6, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 6,020.0000 | 0 | 53.76% | 0.00% |
| Jan. 3, 2023 | CYTOKINETICS INC | $CYTK | WIERENGA WENDALL | Director | A | Common Stock | 253 | $44.35 | 12,533.0000 | 0 | 2.06% | 0.00% |